KCT0006397尚未招募未知
Development of individualized anticoagulation method in atrial fibrillation patients with end stage renal disease
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18?(Year) 至 90?(Year)（—）
- 性别
- All
入选标准
- •End stage renal disease patients with receiving renal replacement therapy
- •with atrial fibrillation
排除标准
- •patients under 18 years old or over 90 years old
研究者
相似试验
已完成
2 期
the effect of plavix in post coronary artery bypass graft/coronary endarterectomy patientsCoronary artery disease.Atherosclerotic heart disease Coronary (artery): atheroma atherosclerosis disease sclerosisIRCT2016102730410N2Babol University of Medical Sciences, Deputy of Research & Technology55
已完成
不适用
Improving the safety and efficacy of anticoagulation therapyTopic: BloodSubtopic: Blood (all Subtopics)Disease: Non-malignant haematologyHaematological DisordersAnticoagulationISRCTN64826232ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)180
进行中（未招募）
1 期
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K - Improving stability of anticoagulation through vitamin KPatients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolismEUCTR2008-006238-87-GBewcastle upon Tyne Hospitals NHS Foundation Trust180
已完成
不适用
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillationJPRN-UMIN000011830ASSAF-K steering committee5,000
尚未招募
不适用
Medication Therapy Management and Pharmacogenetics on Oral AnticoagulantsCTRI/2021/01/030250Manipal Academy of Higher Education